Company Search:
Advanced Search
Sponsored Links
Nicox SA Company Snapshot
Nicox SA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nicox SA with three other pharmaceutical manufacturers in Europe: Premier Veterinary Group PLC of the United Kingdom (2017 sales of £2.53 million [US$3.22 million] ), Summit Therapeutics PLC of the United Kingdom (£2.30 million [US$2.92 million] of which 100% was Drug Discovery), and Biocorp Sa (2.32 million Euro [US$2.63 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Nicox SA
  Stock Performance Chart for Nicox SA
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): 7.97
(Figures in Euro)
1 Week -4.5%   13 Weeks 0.1%  
4 Weeks -10.9%   52 Weeks -19.0%  
Nicox SA Key Data:
  Ticker: COX Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 2,305,000
(Year Ending Jan 2018).
Employees: 28
  Currency: Euro Market Cap: 234,304,857
  Fiscal Yr Ends: December Shares Outstanding: 29,398,351
  Share Type: Actions Ordinaires Closely Held Shares: 2,094,747
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.